| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -9.2e-05 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -5.6e-05 | 1 |